| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.939 | 0.003 | 0.967 | Anticonvulsant | 0.896 0.004 CID_4540 0.967 0.003 CID_135860 | CID_135860 | |
| 0.766 | 0.002 | 0.808 | Benzodiazepine agonist | 0.736 0.002 CID_4540 0.808 0.001 CID_135860 | CID_135860 | |
| 0.649 | 0.003 | 0.776 | GABA receptor agonist | 0.665 0.003 CID_4540 0.776 0.003 CID_135860 | CID_135860 | |
| 0.646 | 0.003 | 0.796 | GABA A receptor antagonist | 0.796 0.002 CID_4540 0.682 0.003 CID_135860 | CID_4540 | |
| 0.641 | 0.005 | 0.683 | GABA C receptor rho-3 antagonist | 0.683 0.004 CID_4540 0.369 0.076 CID_135860 | CID_4540 | |
| 0.638 | 0.003 | 0.803 | GABA receptor antagonist | 0.803 0.002 CID_4540 0.679 0.003 CID_135860 | CID_4540 | |
| 0.536 | 0.007 | 0.536 | Sigma receptor agonist | 0.436 0.017 CID_4540 | ||
| 0.507 | 0.047 | 0.507 | Analgesic | 0.335 0.117 CID_4540 0.46 0.062 CID_135860 | ||
| 0.467 | 0.025 | 0.467 | Nootropic | 0.236 0.121 CID_4540 | ||
| 0.415 | 0.015 | 0.463 | Anesthetic general | 0.333 0.027 CID_4540 0.463 0.01 CID_135860 | CID_135860 | |
| 0.375 | 0.004 | 0.375 | Sodium channel (voltage-gated) blocker | 0.242 0.017 CID_4540 0.198 0.03 CID_135860 | ||
| 0.372 | 0.005 | 0.372 | Sodium channel blocker | 0.228 0.024 CID_4540 0.165 0.047 CID_135860 | ||
| 0.387 | 0.025 | 0.387 | Potassium channel blocker | |||
| 0.358 | 0.03 | 0.474 | Psychostimulant | 0.451 0.016 CID_4540 0.474 0.013 CID_135860 | CID_135860 | |
| 0.322 | 0.038 | 0.363 | Interleukin agonist | 0.363 0.026 CID_4540 | CID_4540 | |
| 0.316 | 0.045 | 0.316 | Potassium channel (Voltage-sensitive) blocker | |||
| 0.274 | 0.005 | 0.274 | Cannabinoid receptor antagonist | 0.073 0.046 CID_4540 0.081 0.039 CID_135860 | ||
| 0.314 | 0.045 | 0.314 | HERG channel blocker | |||
| 0.351 | 0.087 | 0.351 | Antiobesity | |||
| 0.368 | 0.131 | 0.442 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.442 0.067 CID_4540 0.277 0.245 CID_135860 | CID_4540 | |
| 0.25 | 0.015 | 0.425 | Glutamate receptor antagonist | 0.425 0.005 CID_4540 | CID_4540 | |
| 0.242 | 0.013 | 0.318 | GABA C receptor rho-2 antagonist | 0.318 0.005 CID_4540 0.124 0.118 CID_135860 | CID_4540 | |
| 0.229 | 0.021 | 0.229 | Calcium channel blocker | |||
| 0.216 | 0.009 | 0.278 | Glutamate (mGluR) antagonist | 0.278 0.005 CID_4540 | CID_4540 | |
| 0.212 | 0.016 | 0.212 | Nav1.6 sodium channel blocker | 0.156 0.047 CID_4540 0.212 0.016 CID_135860 | ||
| 0.204 | 0.008 | 0.358 | Potassium channel activator | 0.221 0.007 CID_4540 0.358 0.004 CID_135860 | CID_135860 | |
| 0.199 | 0.006 | 0.199 | Nav1.7 sodium channel blocker | 0.101 0.023 CID_4540 0.08 0.033 CID_135860 | ||
| 0.2 | 0.017 | 0.2 | Calcium channel (voltage-sensitive) blocker | 0.106 0.075 CID_135860 | ||
| 0.188 | 0.009 | 0.266 | Glutamate (mGluR group I) antagonist | 0.266 0.005 CID_4540 | CID_4540 | |
| 0.185 | 0.019 | 0.192 | Falcipain inhibitor | 0.192 0.017 CID_4540 | CID_4540 | |
| 0.184 | 0.017 | 0.191 | Falcipain 2 inhibitor | 0.191 0.015 CID_4540 | CID_4540 | |
| 0.246 | 0.084 | 0.295 | Gastrin inhibitor | 0.295 0.036 CID_4540 | CID_4540 | |
| 0.167 | 0.006 | 0.167 | Cannabinoid CB1 receptor antagonist | 0.076 0.03 CID_4540 0.067 0.037 CID_135860 | ||
| 0.155 | 0.004 | 0.155 | Secretase gamma inhibitor | 0.044 0.029 CID_4540 0.122 0.005 CID_135860 | ||
| 0.149 | 0.005 | 0.178 | Glutamate (mGluR5) antagonist | 0.178 0.005 CID_4540 | CID_4540 | |
| 0.189 | 0.048 | 0.239 | ATPase inhibitor | 0.239 0.017 CID_4540 | CID_4540 | |
| 0.144 | 0.003 | 0.201 | Benzodiazepine antagonist | 0.201 0.003 CID_4540 0.068 0.008 CID_135860 | CID_4540 | |
| 0.219 | 0.087 | 0.219 | Antiamyloidogenic | |||
| 0.138 | 0.006 | 0.172 | Phosphodiesterase II inhibitor | 0.172 0.005 CID_4540 | CID_4540 | |
| 0.128 | 0.005 | 0.161 | Phosphodiesterase 2A inhibitor | 0.161 0.005 CID_4540 | CID_4540 | |
| 0.123 | 0.003 | 0.123 | Calcitonin gene-related peptide 1 receptor antagonist | 0.096 0.004 CID_135860 | ||
| 0.125 | 0.01 | 0.125 | Cannabinoid CB2 receptor antagonist | |||
| 0.133 | 0.019 | 0.21 | GABA A receptor agonist | 0.21 0.009 CID_4540 | CID_4540 | |
| 0.168 | 0.057 | 0.168 | NOS3 expression enhancer | 0.157 0.066 CID_4540 0.125 0.105 CID_135860 | ||
| 0.154 | 0.046 | 0.163 | Pregnane X receptor agonist | 0.163 0.033 CID_4540 0.124 0.116 CID_135860 | CID_4540 | |
| 0.108 | 0.007 | 0.108 | Potassium channel intermediate-conductance Ca-activated blocker | 0.082 0.016 CID_4540 | ||
| 0.106 | 0.008 | 0.196 | Cholecystokinin antagonist | 0.099 0.008 CID_4540 0.196 0.005 CID_135860 | CID_135860 | |
| 0.102 | 0.004 | 0.102 | Delayed rectifier potassium channel blocker | 0.043 0.017 CID_135860 | ||
| 0.143 | 0.046 | 0.143 | Beta amyloid protein antagonist | |||
| 0.133 | 0.04 | 0.133 | Nav1.5 sodium channel blocker | 0.112 0.065 CID_4540 0.099 0.087 CID_135860 | ||
| 0.109 | 0.017 | 0.109 | Cannabinoid CB1 receptor agonist | |||
| 0.16 | 0.07 | 0.17 | Cyclin-dependent kinase 8 inhibitor | 0.17 0.061 CID_4540 | CID_4540 | |
| 0.131 | 0.042 | 0.283 | GABA C receptor antagonist | 0.283 0.005 CID_4540 | CID_4540 | |
| 0.118 | 0.033 | 0.118 | Potassium channel (Voltage-sensitive) activator | 0.084 0.079 CID_4540 | ||
| 0.087 | 0.005 | 0.087 | Pregnane X receptor antagonist | 0.065 0.021 CID_4540 0.077 0.008 CID_135860 | ||
| 0.105 | 0.024 | 0.105 | Cannabinoid receptor agonist | |||
| 0.119 | 0.041 | 0.18 | GABA C receptor rho-1 antagonist | 0.18 0.012 CID_4540 | CID_4540 | |
| 0.146 | 0.07 | 0.164 | MAP kinase kinase 4 inhibitor | 0.164 0.04 CID_4540 0.141 0.083 CID_135860 | CID_4540 | |
| 0.125 | 0.052 | 0.228 | 5 Hydroxytryptamine 3A agonist | 0.228 0.009 CID_4540 | CID_4540 | |
| 0.127 | 0.055 | 0.127 | Calcium channel N-type blocker | 0.12 0.063 CID_4540 | ||
| 0.074 | 0.004 | 0.076 | Calcitonin gene-related peptide antagonist | 0.076 0.004 CID_135860 | CID_135860 | |
| 0.081 | 0.012 | 0.108 | Cholecystokinin A antagonist | 0.108 0.007 CID_4540 | CID_4540 | |
| 0.07 | 0.009 | 0.257 | Purinergic P2X4 antagonist | 0.257 0.003 CID_4540 | CID_4540 | |
| 0.063 | 0.005 | 0.077 | Benzodiazepine receptor peripheral-type antagonist | 0.071 0.004 CID_4540 0.077 0.004 CID_135860 | CID_135860 | |
| 0.078 | 0.023 | 0.078 | Calcium channel T-type blocker | 0.061 0.036 CID_135860 | ||
| 0.085 | 0.03 | 0.085 | MAP kinase 7 inhibitor | 0.076 0.06 CID_135860 | ||
| 0.064 | 0.01 | 0.145 | GABA B receptor antagonist | 0.145 0.004 CID_4540 | CID_4540 | |
| 0.08 | 0.026 | 0.08 | Cannabinoid CB2 receptor agonist | |||
| 0.082 | 0.029 | 0.082 | 5 Hydroxytryptamine 3A antagonist | |||
| 0.076 | 0.025 | 0.113 | MDM2 inhibitor | 0.113 0.004 CID_4540 | CID_4540 | |
| 0.214 | 0.163 | 0.214 | Ca(v)3.3 blocker | |||
| 0.067 | 0.019 | 0.067 | Purinergic P2X antagonist | 0.059 0.024 CID_4540 | ||
| 0.102 | 0.057 | 0.102 | Creatine kinase inhibitor | 0.093 0.068 CID_135860 | ||
| 0.16 | 0.116 | 0.364 | Ca2+/calmodulin-dependent kinase II beta inhibitor | 0.364 0.02 CID_4540 | CID_4540 | |
| 0.086 | 0.046 | 0.099 | Transforming growth factor beta 3 antagonist | 0.099 0.024 CID_4540 | CID_4540 | |
| 0.075 | 0.036 | 0.075 | Purinergic P2 antagonist | 0.063 0.045 CID_4540 | ||
| 0.111 | 0.075 | 0.171 | Interleukin 8 antagonist | 0.171 0.023 CID_4540 | CID_4540 | |
| 0.068 | 0.034 | 0.068 | TRPA1 antagonist | 0.06 0.044 CID_4540 | ||
| 0.176 | 0.144 | 0.176 | Cardiotonic | |||
| 0.171 | 0.146 | 0.219 | MAP-kinase-activated kinase 5 inhibitor | 0.166 0.156 CID_4540 0.219 0.083 CID_135860 | CID_135860 | |
| 0.074 | 0.05 | 0.074 | Nav1.8 sodium channel blocker | |||
| 0.039 | 0.015 | 0.138 | Cholecystokinin B antagonist | 0.028 0.024 CID_4540 0.138 0.005 CID_135860 | CID_135860 | |
| 0.086 | 0.063 | 0.156 | Bromodomain-containing protein 2 inhibitor | 0.156 0.007 CID_4540 | CID_4540 | |
| 0.042 | 0.021 | 0.042 | Potassium channel KCNQ activator | |||
| 0.042 | 0.021 | 0.042 | Delayed rectifier potassium channel activator | |||
| 0.064 | 0.044 | 0.064 | Calcium channel P-type blocker | |||
| 0.037 | 0.023 | 0.039 | p53 inhibitor | 0.039 0.021 CID_4540 | CID_4540 | |
| 0.095 | 0.084 | 0.095 | 5 Hydroxytryptamine antagonist | |||
| 0.056 | 0.046 | 0.056 | Androgen agonist | |||
| 0.096 | 0.087 | 0.171 | MAP kinase 13 inhibitor | 0.171 0.028 CID_4540 | CID_4540 | |
| 0.033 | 0.026 | 0.038 | Progesterone antagonist | 0.038 0.023 CID_4540 | CID_4540 | |
| 0.115 | 0.109 | 0.138 | Mannose-6-phosphate isomerase inhibitor | 0.138 0.077 CID_4540 | CID_4540 | |
| 0.044 | 0.038 | 0.072 | Benzodiazepine inverse agonist | 0.072 0.009 CID_4540 | CID_4540 | |
| 0.036 | 0.033 | 0.064 | 5 Hydroxytryptamine 2B agonist | 0.064 0.007 CID_4540 | CID_4540 | |
| 0.056 | 0.054 | 0.097 | 5 Hydroxytryptamine 5A antagonist | 0.097 0.016 CID_4540 | CID_4540 | |
| 0.028 | 0.026 | 0.028 | Liver X receptor antagonist | |||
| 0.05 | 0.049 | 0.05 | 5 Hydroxytryptamine 3 antagonist | |||
| 0.119 | 0.119 | 0.122 | Thiol protease inhibitor | 0.122 0.113 CID_4540 | CID_4540 | |
| 0.044 | 0.044 | 0.083 | 5 Hydroxytryptamine 2 agonist | 0.083 0.014 CID_4540 | CID_4540 | |
| 0.104 | 0.106 | 0.113 | NADPH oxidase inhibitor | 0.113 0.092 CID_4540 | CID_4540 | |
| 0.051 | 0.055 | 0.094 | 5 Hydroxytryptamine 5 antagonist | 0.094 0.016 CID_4540 | CID_4540 | |
| 0.096 | 0.105 | 0.171 | MAP kinase 12 inhibitor | 0.171 0.032 CID_4540 | CID_4540 | |
| 0.04 | 0.05 | 0.06 | Bromodomain-containing protein 3 inhibitor | 0.06 0.02 CID_4540 | CID_4540 | |
| 0.078 | 0.096 | 0.117 | Lanosterol 14 alpha demethylase inhibitor | 0.117 0.034 CID_4540 | CID_4540 | |
| 0.18 | 0.198 | 0.288 | 5 Hydroxytryptamine uptake stimulant | 0.288 0.052 CID_4540 | CID_4540 | |
| 0.046 | 0.066 | 0.063 | 5 Hydroxytryptamine 7 agonist | 0.063 0.027 CID_4540 | CID_4540 | |
| 0.126 | 0.146 | 0.295 | MAP kinase kinase 2 inhibitor | 0.295 0.037 CID_4540 | CID_4540 | |
| 0.051 | 0.072 | 0.083 | Corticotropin releasing factor 2 receptor antagonist | 0.083 0.015 CID_4540 | CID_4540 | |
| 0.049 | 0.072 | 0.056 | Potassium channel (Ca-activated) blocker | 0.056 0.05 CID_4540 | CID_4540 | |
| 0.152 | 0.175 | 0.261 | ErbB-1 antagonist | 0.261 0.046 CID_4540 | CID_4540 | |
| 0.053 | 0.081 | 0.099 | Potassium channel large-conductance Ca-activated activator | 0.099 0.024 CID_4540 | CID_4540 | |
| 0.057 | 0.086 | 0.094 | Phospholipase D inhibitor | 0.094 0.019 CID_4540 | CID_4540 | |
| 0.053 | 0.086 | 0.08 | Transforming growth factor antagonist | 0.08 0.035 CID_4540 | CID_4540 | |
| 0.023 | 0.057 | 0.041 | RNA-directed RNA polymerase inhibitor | 0.041 0.018 CID_135860 | CID_135860 | |
| 0.036 | 0.073 | 0.088 | Glutamate (mGluR1) antagonist | 0.088 0.02 CID_4540 | CID_4540 | |
| 0.062 | 0.099 | 0.21 | Potassium channel (Ca-activated) activator | 0.21 0.013 CID_4540 | CID_4540 | |
| 0.109 | 0.148 | 0.188 | TRKC antagonist | 0.188 0.074 CID_4540 | CID_4540 | |
| 0.026 | 0.065 | 0.061 | Factor XIa inhibitor | 0.061 0.012 CID_4540 | CID_4540 | |
| 0.039 | 0.079 | 0.054 | Antiviral (Hepatitis D) | 0.054 0.029 CID_4540 | CID_4540 | |
| 0.037 | 0.078 | 0.107 | Pim-2 kinase inhibitor | 0.107 0.013 CID_4540 | CID_4540 | |
| 0.066 | 0.11 | 0.134 | Pim-3 kinase inhibitor | 0.134 0.024 CID_4540 | CID_4540 | |
| 0.069 | 0.113 | 0.143 | DNA directed RNA polymerase inhibitor | 0.143 0.026 CID_4540 | CID_4540 | |
| 0.033 | 0.079 | 0.046 | Alpha 1L adrenoreceptor agonist | 0.046 0.023 CID_4540 | CID_4540 | |
| 0.048 | 0.094 | 0.067 | Protein kinase C beta inhibitor | 0.063 0.062 CID_4540 0.067 0.054 CID_135860 | CID_135860 | |
| 0.045 | 0.092 | 0.116 | Prostaglandin-E synthase inhibitor | 0.116 0.021 CID_4540 | CID_4540 | |
| 0.072 | 0.121 | 0.1 | Electrolyte absorption antagonist | 0.095 0.065 CID_4540 0.1 0.058 CID_135860 | CID_135860 | |
| 0.026 | 0.075 | 0.057 | Acid-sensing ion channel blocker | 0.057 0.011 CID_4540 | CID_4540 | |
| 0.078 | 0.128 | 0.127 | Nav1.3 sodium channel blocker | 0.127 0.066 CID_4540 | CID_4540 | |
| 0.045 | 0.099 | 0.078 | 5 Hydroxytryptamine 2A antagonist | 0.078 0.06 CID_4540 | CID_4540 | |
| 0.018 | 0.072 | 0.06 | Kinesin-like protein 1 inhibitor | 0.06 0.014 CID_4540 | CID_4540 | |
| 0.018 | 0.072 | 0.06 | Kinesin antagonist | 0.06 0.014 CID_4540 | CID_4540 | |
| 0.029 | 0.086 | 0.05 | Adenylate cyclase 1 inhibitor | 0.05 0.026 CID_4540 | CID_4540 | |
| 0.013 | 0.074 | 0.028 | HCV NS5B polymerase inhibitor | 0.028 0.027 CID_135860 | CID_135860 | |
| 0.051 | 0.112 | 0.086 | 5 Hydroxytryptamine 2C antagonist | 0.086 0.056 CID_4540 | CID_4540 | |
| 0.071 | 0.134 | 0.104 | Glutamate release inhibitor | 0.104 0.037 CID_4540 | CID_4540 | |
| 0.113 | 0.177 | 0.185 | Ca2+/calmodulin-dependent protein kinase inhibitor | 0.185 0.085 CID_4540 | CID_4540 | |
| 0.033 | 0.101 | 0.071 | Phosphodiesterase VII inhibitor | 0.071 0.034 CID_4540 | CID_4540 | |
| 0.028 | 0.103 | 0.053 | Transforming growth factor beta 1 antagonist | 0.053 0.031 CID_4540 | CID_4540 | |
| 0.055 | 0.132 | 0.151 | Pim-1 kinase inhibitor | 0.151 0.027 CID_4540 | CID_4540 | |
| 0.066 | 0.144 | 0.138 | MAP kinase kinase 1 inhibitor | 0.138 0.021 CID_4540 | CID_4540 | |
| 0.058 | 0.137 | 0.093 | 5 Hydroxytryptamine 2 antagonist | 0.093 0.078 CID_4540 | CID_4540 | |
| 0.03 | 0.11 | 0.088 | 5 Hydroxytryptamine 2A agonist | 0.088 0.021 CID_4540 | CID_4540 | |
| 0.021 | 0.103 | 0.055 | Adenosine A2b receptor antagonist | 0.055 0.028 CID_4540 | CID_4540 | |
| 0.012 | 0.095 | 0.032 | Potassium channel small-conductance Ca-activated activator | 0.032 0.021 CID_4540 | CID_4540 | |
| 0.017 | 0.1 | 0.04 | Factor XI inhibitor | 0.04 0.016 CID_4540 | CID_4540 | |
| 0.133 | 0.218 | 0.281 | 5 Hydroxytryptamine release stimulant | 0.281 0.076 CID_4540 | CID_4540 | |
| 0.04 | 0.126 | 0.075 | Aryl hydrocarbon receptor antagonist | 0.075 0.032 CID_4540 | CID_4540 | |
| 0.065 | 0.151 | 0.095 | Nav1.1 sodium channel blocker | 0.095 0.072 CID_135860 | CID_135860 | |
| 0.076 | 0.163 | 0.111 | Alkaline phosphatase inhibitor | 0.111 0.098 CID_4540 | CID_4540 | |
| 0.029 | 0.118 | 0.054 | Potassium channel (ATP-sensitive) activator | 0.054 0.024 CID_4540 | CID_4540 | |
| 0.062 | 0.152 | 0.097 | Protein kinase C zeta inhibitor | 0.097 0.054 CID_4540 0.082 0.081 CID_135860 | CID_4540 | |
| 0.031 | 0.121 | 0.056 | Potassium channel (Inward rectifier) activator | 0.056 0.025 CID_4540 | CID_4540 | |
| 0.121 | 0.215 | 0.276 | Cyclic AMP phosphodiesterase inhibitor | 0.276 0.052 CID_4540 | CID_4540 | |
| 0.071 | 0.165 | 0.111 | Phosphodiesterase inhibitor | 0.111 0.092 CID_4540 | CID_4540 | |
| 0.047 | 0.142 | 0.124 | Glycine receptor antagonist | 0.124 0.016 CID_4540 | CID_4540 | |
| 0.057 | 0.154 | 0.112 | Ferrochelatase inhibitor | 0.112 0.06 CID_4540 | CID_4540 | |
| 0.044 | 0.142 | 0.106 | Phosphodiesterase 3A inhibitor | 0.106 0.028 CID_4540 | CID_4540 | |
| 0.022 | 0.121 | 0.056 | Dihydroorotase inhibitor | 0.056 0.019 CID_4540 | CID_4540 | |
| 0.063 | 0.163 | 0.116 | TRKA antagonist | 0.116 0.07 CID_4540 | CID_4540 | |
| 0.065 | 0.172 | 0.119 | Tyrosine-protein kinase receptor antagonist | 0.119 0.088 CID_4540 | CID_4540 | |
| 0.031 | 0.14 | 0.071 | MAP kinase 14 inhibitor | 0.071 0.054 CID_4540 | CID_4540 | |
| 0.023 | 0.133 | 0.071 | p38 MAP kinase inhibitor | 0.071 0.044 CID_4540 | CID_4540 | |
| 0.02 | 0.133 | 0.053 | Plasminogen activator inhibitor | 0.053 0.045 CID_135860 | CID_135860 | |
| 0.06 | 0.176 | 0.189 | MAP kinase kinase inhibitor | 0.189 0.032 CID_4540 | CID_4540 | |
| 0.015 | 0.132 | 0.047 | AMPA receptor antagonist | 0.047 0.034 CID_4540 | CID_4540 | |
| 0.048 | 0.167 | 0.129 | Platelet activating factor antagonist | 0.129 0.057 CID_4540 | CID_4540 | |
| 0.006 | 0.126 | 0.036 | NMDA receptor glycine site antagonist | 0.036 0.009 CID_4540 | CID_4540 | |
| 0.027 | 0.147 | 0.109 | MAP kinase 11 inhibitor | 0.109 0.03 CID_4540 | CID_4540 | |
| 0.027 | 0.154 | 0.064 | Cyclin D1 inhibitor | 0.064 0.037 CID_4540 | CID_4540 | |
| 0.009 | 0.141 | 0.032 | Kainate receptor 2 antagonist | 0.032 0.028 CID_4540 | CID_4540 | |
| 0.127 | 0.266 | 0.217 | RNA-directed DNA polymerase inhibitor | 0.217 0.077 CID_4540 | CID_4540 | |
| 0.049 | 0.188 | 0.106 | 5 Hydroxytryptamine 2B antagonist | 0.106 0.077 CID_4540 | CID_4540 | |
| 0.03 | 0.173 | 0.104 | Cyclin B3 inhibitor | 0.104 0.027 CID_4540 | CID_4540 | |
| 0.073 | 0.217 | 0.299 | Aryl hydrocarbon receptor agonist | 0.299 0.061 CID_4540 | CID_4540 | |
| 0.151 | 0.303 | 0.288 | Calcium channel activator | 0.288 0.104 CID_4540 | CID_4540 | |
| 0.073 | 0.227 | 0.102 | Transcription factor STAT6 inhibitor | 0.102 0.1 CID_4540 | CID_4540 | |
| 0.032 | 0.194 | 0.057 | Phosphodiesterase 1A inhibitor | 0.057 0.048 CID_4540 | CID_4540 | |
| 0.044 | 0.207 | 0.227 | Glycogen synthase kinase-3 alpha inhibitor | 0.227 0.034 CID_4540 | CID_4540 | |
| 0.048 | 0.212 | 0.129 | Proto-oncogene tyrosine-protein kinase Yes inhibitor | 0.129 0.075 CID_4540 | CID_4540 | |
| 0.074 | 0.239 | 0.203 | LIM domain kinase 1 inhibitor | 0.203 0.061 CID_4540 | CID_4540 | |
| 0.07 | 0.243 | 0.142 | Protein kinase (CK1) gamma 3 inhibitor | 0.142 0.099 CID_4540 | CID_4540 | |
| 0.101 | 0.276 | 0.217 | Death-associated protein kinase 2 inhibitor | 0.217 0.024 CID_4540 | CID_4540 | |
| 0.127 | 0.302 | 0.25 | Nitric-oxide synthase stimulant | 0.25 0.032 CID_4540 | CID_4540 | |
| 0.047 | 0.23 | 0.107 | Beta glucuronidase inhibitor | 0.107 0.06 CID_4540 | CID_4540 | |
| 0.039 | 0.223 | 0.073 | Chymotrypsin inhibitor | 0.073 0.065 CID_135860 | CID_135860 | |
| 0.061 | 0.247 | 0.118 | Protein kinase (CK1) gamma 1 inhibitor | 0.118 0.1 CID_4540 | CID_4540 | |
| 0.015 | 0.2 | 0.048 | NMDA receptor subunit 3B antagonist | 0.048 0.027 CID_4540 | CID_4540 | |
| 0.069 | 0.254 | 0.136 | Aurora-C kinase inhibitor | 0.136 0.072 CID_4540 | CID_4540 | |
| 0.016 | 0.203 | 0.078 | NMDA receptor glycine site agonist | 0.078 0.03 CID_4540 | CID_4540 | |
| 0.074 | 0.264 | 0.151 | Polo-like kinase-3 inhibitor | 0.151 0.083 CID_4540 | CID_4540 | |
| 0.035 | 0.226 | 0.081 | MAP-kinase-activated kinase inhibitor | 0.081 0.061 CID_4540 | CID_4540 | |
| 0.043 | 0.234 | 0.079 | GABA B receptor agonist | 0.079 0.043 CID_4540 | CID_4540 | |
| 0.131 | 0.327 | 0.178 | 5 Hydroxytryptamine 3E antagonist | 0.178 0.111 CID_4540 | CID_4540 | |
| 0.078 | 0.295 | 0.135 | MAP kinase 3 inhibitor | 0.135 0.095 CID_4540 | CID_4540 | |
| 0.024 | 0.243 | 0.125 | NMDA receptor antagonist | 0.125 0.033 CID_4540 | CID_4540 | |
| 0.009 | 0.235 | 0.104 | Phosphodiesterase 3B inhibitor | 0.104 0.01 CID_4540 | CID_4540 | |
| 0.025 | 0.256 | 0.054 | Sodium/calcium exchanger inhibitor | 0.054 0.027 CID_4540 | CID_4540 | |
| 0.07 | 0.302 | 0.21 | Platelet aggregation inhibitor | 0.21 0.074 CID_4540 | CID_4540 | |
| 0.035 | 0.268 | 0.126 | EphA2 antagonist | 0.126 0.049 CID_4540 | CID_4540 | |
| 0.042 | 0.276 | 0.108 | Protein kinase (CK1) gamma inhibitor | 0.108 0.105 CID_4540 | CID_4540 | |
| 0.024 | 0.265 | 0.074 | MAP-kinase-activated kinase 2 inhibitor | 0.074 0.052 CID_4540 | CID_4540 | |
| 0.035 | 0.3 | 0.092 | AMP-activated protein kinase stimulant | 0.092 0.081 CID_4540 | CID_4540 | |
| 0.027 | 0.307 | 0.173 | Polo-like kinase-4 inhibitor | 0.173 0.024 CID_4540 | CID_4540 | |
| 0.141 | 0.428 | 0.283 | 5 Hydroxytryptamine release inhibitor | 0.283 0.186 CID_4540 | CID_4540 | |
| 0.033 | 0.339 | 0.14 | Ca2+/calmodulin-dependent kinase II gamma inhibitor | 0.14 0.096 CID_4540 | CID_4540 | |
| 0.043 | 0.355 | 0.11 | Interleukin 1 antagonist | 0.11 0.104 CID_4540 | CID_4540 | |
| 0.074 | 0.395 | 0.124 | Death-associated protein kinase 1 inhibitor | 0.124 0.099 CID_4540 | CID_4540 | |
| 0.041 | 0.365 | 0.116 | Cytokine production inhibitor | 0.116 0.094 CID_4540 | CID_4540 | |
| 0.032 | 0.366 | 0.143 | Dual specificity tyrosine-phosphorylation regulated kinase 3 inhibitor | 0.143 0.126 CID_4540 | CID_4540 | |
| 0.014 | 0.354 | 0.091 | Phosphodiesterase III inhibitor | 0.091 0.027 CID_4540 | CID_4540 | |
| 0.087 | 0.437 | 0.242 | Ca2+/calmodulin-dependent kinase II alpha inhibitor | 0.237 0.119 CID_4540 0.242 0.114 CID_135860 | CID_135860 | |
| 0.031 | 0.442 | 0.142 | Death-associated protein kinase 3 inhibitor | 0.142 0.136 CID_4540 | CID_4540 | |
| 0.075 | 0.505 | 0.159 | Cyclin-dependent kinase 3 inhibitor | 0.159 0.078 CID_4540 | CID_4540 | |
| 0.027 | 0.483 | 0.104 | Nav1.4 sodium channel blocker | 0.104 0.07 CID_4540 | CID_4540 | |
| 0.051 | 0.516 | 0.151 | Ca2+/calmodulin-dependent kinase I alpha inhibitor | 0.151 0.144 CID_4540 | CID_4540 | |
| 0.074 | 0.785 | 0.335 | Calcium channel L-type activator | 0.335 0.129 CID_4540 | CID_4540 | |
| 0.002 | 0.948 | 0.031 | 1,3-Beta-glucan synthase inhibitor | 0.031 0.012 CID_135860 | CID_135860 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |